Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.87−0.54 (-7.29%)
Close on Nov 18, 2026Market cap $622.17MP/E –Yield –
Verastem net income
Net income is the profit left for shareholders after every expense, interest and tax.
Verastem's net income for the twelve months ending Jun 30, 2026 was -$202.70M. For fiscal 2025 it was -$209.47M. The highest annual figure on record is -$13.68M in fiscal 2011.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$209.47M | – |
| FY2024 | Dec 31, 2024 | -$130.64M | – |
| FY2023 | Dec 31, 2023 | -$87.37M | – |
| FY2022 | Dec 31, 2022 | -$73.81M | – |
| FY2021 | Dec 31, 2021 | -$71.20M | – |
| FY2020 | Dec 31, 2020 | -$67.73M | – |
| FY2019 | Dec 31, 2019 | -$149.21M | – |
| FY2018 | Dec 31, 2018 | -$72.43M | – |
| FY2017 | Dec 31, 2017 | -$67.80M | – |
| FY2016 | Dec 31, 2016 | -$36.44M | – |
| FY2015 | Dec 31, 2015 | -$57.87M | – |
| FY2014 | Dec 31, 2014 | -$53.37M | – |
| FY2013 | Dec 31, 2013 | -$41.20M | – |
| FY2012 | Dec 31, 2012 | -$31.98M | – |
| FY2011 | Dec 31, 2011 | -$13.68M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.67M | – |
| Q1 FY2026 | Mar 31, 2026 | -$36.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$32.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$98.52M | – |
| Q2 FY2025 | Jun 30, 2025 | -$25.93M | – |
| Q1 FY2025 | Mar 31, 2025 | -$52.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$64.55M | – |
| Q1 FY2024 | Jun 30, 2024 | -$42.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$27.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.00M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.09M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.95M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.96M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.79M | -273.4% |
| Q2 FY2021 | Jun 30, 2021 | -$16.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.86M | – |
| Q3 FY2020 | Sep 30, 2020 | $13.14M | – |
| Q2 FY2020 | Jun 30, 2020 | -$23.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$37.99M | – |
| Q4 FY2019 | Dec 31, 2019 | -$38.77M | – |
| Q3 FY2019 | Sep 30, 2019 | -$30.14M | – |
| Q2 FY2019 | Jun 30, 2019 | -$42.19M | – |
| Q1 FY2019 | Mar 31, 2019 | -$38.10M | – |
| Q4 FY2018 | Dec 31, 2018 | -$11.35M | – |
| Q3 FY2018 | Sep 30, 2018 | -$21.67M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$21.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$18.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$23.13M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.44M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.01M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.66M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.92M | – |
| Q2 FY2016 | Jun 30, 2016 | -$8.57M | – |
See a number that looks wrong?